|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/10 | |
| A61K 38/13 | |||
| A61K 47/32 | |||
| A61K 47/36 | |||
| A61K 47/38 | |||
| C07K 1/30 | |||
| C07K 7/64 |
| (11) | Patento numeris | 2779992 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12788092.0 |
| Europos patento paraiškos padavimo data | 2012-11-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-09-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-02-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/064988 |
| Data | 2012-11-14 |
| (87) | Numeris | WO 2013/074610 |
| Data | 2013-05-23 |
| (30) | Numeris | Data | Šalis |
| 201161559838 P | 2011-11-15 | US | |
| 201161563199 P | 2011-11-23 | US |
| (72) |
BLANDA, Wendy M., US
ATTAR, Mayssa, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | SUSTAINED ACTION FORMULATION OF CYCLOSPORIN FORM 2 |
| SUSTAINED ACTION FORMULATION OF CYCLOSPORIN FORM 2 |